Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,039 public trials 566 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

Multi-center, Open-label, Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)

NCT04045795

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • ~Banner MD Anderson Cancer Center Site Number : 8400005 Gilbert, Arizona, United States
  • City of Hope Site Number : 8400002 Duarte, California, United States
  • Gabrail Cancer Center Site Number : 8400001 Canton, Ohio, United States
  • Investigational Site Number : 0360002 Blacktown, New South Wales, Australia
View all 14 locations
View Trial Details
Completed

First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

NCT04000282

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • City of Hope Site Number : 8400002 Duarte, California, United States
  • Dana Farber Cancer Institute Site Number : 8400003 Boston, Massachusetts, United States
  • Mayo Clinic of Rochester Site Number : 8400005 Rochester, Minnesota, United States
  • UNC Chapel Hill Site Number : 8400006 Chapel Hill, North Carolina, United States
View Trial Details
Completed

Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma

NCT01745588

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering West Harrison Harrison, New York, United States
View Trial Details
Completed

BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I)

NCT04018248

Conditions
B Cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +36 more
Locations
  • Henry Ford Hospital Detroit, Michigan, United States
  • National Cancer Center Goyang-si, Gyeonggi-do, South Korea
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
  • Chonnam National University Hwasun Hospital Hwasun, Jeollanam-do, South Korea
View Trial Details
Completed

Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet

NCT04191616

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Rocky Mountain Cancer Centers Denver Midtown Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Affiliated Oncologists, LLC Chicago Ridge, Illinois, United States
View all 46 locations
View Trial Details

Related conditions